Bipolar Depression and ketamine research
Why bipolar disorder requires special caution in ketamine therapy, and what current research suggests about the bipolar depressive phase.
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
If you need help right now
- United States: Call or text 988 (Suicide & Crisis Lifeline), available 24/7.
- Outside the US: Contact your local emergency number, or find a helpline via findahelpline.com.
- If you are in immediate danger, go to your nearest emergency department.
This page answers one question: what does published research currently say about ketamine and bipolar depression, and where does that evidence stop? It is a research overview, not treatment guidance.
Overview
Bipolar disorder involves both depressive and manic or hypomanic episodes. The depressive phase is often the most disabling and treatment-resistant aspect, but treatments effective in unipolar depression can sometimes trigger mood elevation in bipolar patients.
Conventional treatment
Major guidelines list lithium, lamotrigine, quetiapine, and lurasidone among first-line options for bipolar I depression, with valproate used mainly in combination [4]; other atypical antipsychotics such as cariprazine are also approved for bipolar depression. Adjunctive psychotherapy is part of good care. Antidepressant monotherapy is not recommended for bipolar I depression [4].
Where ketamine fits
Small randomized trials found that a single IV ketamine infusion, added to lithium or valproate, rapidly improved bipolar depression, with benefits fading over several days [1,2]. Manic symptoms were uncommon in these trials, but they were too small to establish the true switch risk.
What current evidence suggests
Diazgranados 2010 and Zarate 2012 reported rapid antidepressant effects in bipolar depression with concurrent mood stabilizers [1,2]. A 2024 overview of meta-analyses found that in bipolar depression the advantage over control faded from about day 7 onward, and rated the overall evidence quality as low [3]. The evidence base is meaningful but smaller than for unipolar TRD.
Frequently asked questions
Can ketamine trigger mania?+
Switch risk exists. Manic symptoms were uncommon in small trials of patients taking mood stabilizers, but the risk has not been well quantified. Close monitoring is required.
Is it appropriate for bipolar I or II?+
Both have been studied, but management requires a psychiatrist experienced in bipolar disorder. It is not a first-line option.
References
- Diazgranados N et al. — A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry · 2010 RCT
- Zarate CA Jr et al. — Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biological Psychiatry / PubMed · 2012 RCT
- Rodolico A et al. — Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis. Frontiers in Psychiatry · 2024 Meta-analysis
- Yatham LN et al. — CANMAT and ISBD 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders · 2018 Guideline
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.

